GL1X · GenesisL1 explorer

MolNFT v1 · #160997 · protein

Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin head domain of A/BEIJING/262/95(H1N1)

6Q0I: “Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with influenza hemagglutinin…”. X-ray diffraction, 1 ligand (NAG), 5 pockets (best druggability 0.59). MolNFT v1 #160997 on GenesisL1: 3D structure…

PDB
6Q0I
Type
protein
Length
650 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin; Fab heavy chain; Fab lambda chain
UniProt
B4UPF7
Ligands
NAG
Pockets
5 · best druggability 0.59

Structure

x-ray diffraction · 3 distinct chains · 7% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHemagglutininprotein20710% helix, 39% strandB4UPF7
HFab heavy chainprotein2315% helix, 48% strand—
LFab lambda chainprotein2126% helix, 50% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
  • GOL · Glycerol · additive · chains H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15480.590.7359empty
23040.570.7752empty
31080.440.7924empty
4970.440.7922empty
5540.250.7319empty

Interfaces

2 interfaces between chains.

  • H–L · 2023 Ų buried · 21 hydrogen bonds · protein-protein
  • A–H · 894 Ų buried · 24 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 6Q0I · Inferred intermediate I-7 (I-7-6) of the human antibody lineage 652 in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.